Albuminuria and diabetic retinopathy in type 2 diabetes mellitus sankara nethralaya diabetic retinopathy epidemiology and molecular genetic study (SN-DREAMS, report 12)

Diabetology and Metabolic Syndrome

Volumn 3, Issue 1, 2011, Pages

  Rani, Padmaja K ^a   Raman, Rajiv ^a   Gupta, Aditi ^a   Pal, Swakshyar S ^a   Kulothungan, Vaitheeswaran ^b   Sharma, Tarun ^a  

^a SANKARA NETHRALAYA   (India)

^b Department of Preventive Ophthalmology ^*  (India)

Author keywords

Diabetic Retinopathy; Macroalbuminuria; Microalbuminuria; Risk factor; Type 2 Diabetes

Indexed keywords

ALBUMIN; HEMOGLOBIN A1C;

ADULT; ARTICLE; BODY MASS; CLINICAL STUDY; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; EYE EXAMINATION; FEMALE; HUMAN; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PHOTOGRAPHY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

EID: 80955176418     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-3-9     Document Type: Article

References (60)

1. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. S Wild G Roglic A Green R Sicree H King, Diabetes Care 2004 27 1047 1053 10.2337/diacare.27.5.1047 15111519 (Pubitemid 38579764)
2. Prevalence and risk factors of diabetic nephropathy in an urban South Indian population: the Chennai Urban Rural Epidemiology Study (CURES 45). RI Unnikrishnan M Rema R Pradeepa M Deepa CS Shanthirani R Deepa V Mohan, Diabetes Care 2007 30 2019 2024 10.2337/dc06-2554 17488949 (Pubitemid 47219412)
3. Prevalence of small vessel and large vessel disease in diabetic patients from 14 centers. The World Health Organization Multinational Study of Vascular Disease in Diabetics. Diabetes Drafting Group. Diabetologia 1985 28 Suppl 615 640 4065455
4. Microalbuminuria and retinopathy in a diabetic population of Cameroon. E Sobngwi JC Mbanya EN Moukouri KB Ngu, Diabetes Res Clin Pract 1999 44 191 196 10.1016/S0168-8227(99)00052-2 10462142 (Pubitemid 29287188)
5. Retinopathy is independently related to microalbuminuria in type 2 diabetes mellitus. O Wirta A Pasternack J Mustonen P Laippala Y Lähde, Clin Nephrol 1999 51 329 334 10404692 (Pubitemid 29261691)
6. WHO-Magnitude and causes of Visual impairment, 2010 http://www.who.int/ mediacentre/factsheets/fs282/en/
7. The temporal development of retinopathy and nephropathy in type 1 diabetes mellitus during 15 years diabetes duration. M Lovestam-Adrian E Agardh CD Agardh, Diabetes Res Clin Pract 1999 45 15 23 10.1016/S0168-8227(99)00055-8 10499881 (Pubitemid 29356120)
8. Comparison of the prevalence and associated features of abnormal albumin excretion in insulin-dependent and non-insulin-dependent diabetes. SM Marshall KG Alberti, Q J Med 1989 70 61 71 2594949 (Pubitemid 19083973)
9. A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM. A Neil M Hawkins M Potok M Thorogood D Cohen J Mann, Diabetes Care 1993 16 996 1003 10.2337/diacare.16.7.996 8359108 (Pubitemid 23184530)
10. Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. R Retnakaran CA Cull KI Thorne AI Adler RR Holman UKPDS Study Group, Diabetes 2006 55 1832 1839 10.2337/db05-1620 16731850 (Pubitemid 44324140)
11. Occurrence and predictors of retinopathy and visual acuity in Type 2 diabetic patients and control subjects 10-year follow-up from the diagnosis. RM Voutilainen-Kaunisto ME Terasvirta MIJ Uasitupa LK Niskanen, J Diab Comp 2001 15 24 33 10.1016/S1056-8727(00)00126-4 (Pubitemid 32203888)
12. Epidemiology of renal involvement in newly-diagnosed middle-aged and elderly diabetic patients. Cross-sectional data from the population-based study "Diabetes Care in General Practice", Denmark. NdF Olivarius AH Andreasen N Keiding CE Mogensen, Diabetologia 1993 36 1007 1016 10.1007/BF02374492 8243848 (Pubitemid 23288769)
13. Longitudinal studies of incidence and progression of diabetic retinopathy assessed by retinal photography in Pima Indians. HC Looker J Krakoff WC Knowler PH Bennett R Klein RL Hanson, Diabetes Care 2003 26 320 326 10.2337/diacare.26.2.320 12547856 (Pubitemid 36929049)
14. Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. S Savage RO Estacio B Jeffers RW Schrier, Diabetes Care 1996 19 1243 1248 10.2337/diacare.19.11.1243 8908388 (Pubitemid 26363440)
15. Sankara Nethralaya-Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS 1): study design and research methodology. S Agarwal R Raman PG Paul PK Rani S Uthra R Gayathree C McCarty G Kumaramanickavel T Sharma, Ophthalmic Epidemiol 2005 12 143 153 10.1080/09286580590932734 16019696 (Pubitemid 41702827)
16. Tests of glycemia in diabetes. DE Goldstein RR Little RA Lorenz JI Malone DM Nathan CM Peterson American Diabetes Association, Diabetes Care 2003 26 Suppl 1 106 108
17. Interest of Clinitek Microalbumin in screening for microalbuminuria: results of a multicentre study in 302 diabetic patients. JP Le Floch M Marre M Rodier P Passa, Diabetes Metab 2001 27 36 39 11240444 (Pubitemid 32198878)
18. The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population. RT Gansevoort JC Verhave HL Hillege JG Burgerhof SJ Bakker D de Zeeuw PE de Jong for the PREVEND Study Group, Kidney Int Suppl 2005 94 28 35 15752236
19. A comparative evaluation of various methods for microalbuminuria screening. PA Sarafidis J Riehle Z Bogojevic E Basta A Chugh GL Bakris, Am J Nephrol 2008 28 324 329 10.1159/000111825 18046079
20. Nephropathy in Diabetes. ME Molitch RA DeFronzo MJ Franz WF Keane CE Mogensen HH Parking MW Steffes American Diabetes Association, Diabetes Care 2004 27 Suppl 1 79 83
21. An alternative method of grading diabetic retinopathy. R Klein BE Klein YL Magli RJ Brothers SM Meuer SE Moss MD Davis, Ophthalmology 1986 93 1183 1187 3101021 (Pubitemid 17211516)
22. High prevalence of type 2 diabetes in an urban settlement in Kerala, India. V Raman Kutty A Joseph CR Soman, Ethn Health 1999 4 231 239 10.1080/13557859998010 10705560 (Pubitemid 30042518)
23. Prevalence of diabetes, impaired fasting glucose and insulin resistance syndrome in an urban Indian population. A Gupta R Gupta M Sarna S Rastogi VP Gupta K Kothari, Diabetes Res Clin Pract 2003 61 69 76 10.1016/S0168-8227(03) 00085-8 12849925 (Pubitemid 36808845)
24. Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in the Kashmir Valley of the Indian subcontinent. AH Zargar AK Khan SR Masoodi BA Laway AI Wani MI Bashir FA Dar, Diabetes Res Clin Pract 2000 47 135 146 10.1016/S0168-8227(99)00110-2 10670914
25. High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. A Ramachandran C Snehalatha A Kapur V Vijay V Mohan AK Das PV Rao CS Yajnik KM Prasanna Kumar JD Nair Diabetes Epidemiology Study Group in India (DESI), Diabetologia 2001 44 1094 1101 10.1007/ s001250100627 11596662 (Pubitemid 32835500)
26. Secular trends in the prevalence of diabetes and glucose tolerance in urban South India - the Chennai Urban Rural Epidemiology Study (CURES-17). V Mohan M Deepa R Deepa CS Shanthirani S Farooq A Ganesan M Datta, Diabetologia 2006 49 1175 1178 10.1007/s00125-006-0219-2 16570158
27. Baseline analysis of renal function in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group [corrected]. ME Molitch MW Steffes PA Cleary DM Nathan, Kidney Int 1993 43 668 674 10.1038/ki.1993.96 8455366 (Pubitemid 23071951)
28. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study. MA Gall P Hougaard K Borch-Johnsen HH Parving, BMJ 1997 314 783 788 9080995 (Pubitemid 27117048)
29. Retinopathy and macro-albuminuria in type 2 diabetic patients. T Phoksunthorn D Thatsnarong, J Med Assoc Thai 2007 90 684 687 17487122 (Pubitemid 46631813)
30. Incidence and determinants of microalbuminuria in Koreans with type 2 diabetes. JY Park HK Kim YE Chung SW Kim SK Hong KU Lee, Diabetes Care 1998 21 530 534 10.2337/diacare.21.4.530 9571337 (Pubitemid 28172929)
31. Diabetic retinopathy and microalbuminuria in lean type 2 diabetes mellitus. SK Singh A Behre MK Singh, J Assoc Physicians India 2001 49 439 441 11762615 (Pubitemid 33641646)
32. Evaluation of retinal involvement in type 2 diabetics with microalbuminuria. P Durruty C Carpentier P Krause RM Garcia de los, Rev Med Chil 2000 128 1085 1092 11349506
33. Proliferative diabetic retinopathy is associated with microalbuminuria in patients with type 2 diabetes. MC Boelter JL Gross LH Canani LA Costa HR Lisboa GS Três J Lavinsky MJ Azevedo, Braz J Med Biol Res 2006 39 1033 1039 16906278
34. High systolic blood pressure increases prevalence and severity of retinopathy in NIDDM patients. M Cignarelli ML De Cicco A Damato A Paternostro S Pagliarini S Santoro L Cardia G De Pergola R Giorgino, Diabetes Care 1992 15 1002 1008 10.2337/diacare.15.8.1002 1505300
35. The association of microalbuminuria with diabetic retinopathy. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. KJ Cruickshanks LL Ritter R Klein SE Moss, Ophthalmology 1993 100 862 867 8510898 (Pubitemid 23163496)
36. The relationship between microalbuminuria by using urine dipsticks and diabetic retinopathy in type 2 diabetes. S Potisat A Srisubat U Krairttichai A Jongsareejit, J Med Assoc Thai 2008 91 846 851 18697383 (Pubitemid 351977863)
37. Renal pathology patterns in type II diabetes mellitus: relationship with retinopathy. The Collaborative Study Group. MM Shwartz EJ Lewis T Leonard-Martin JB Lewis D Batlle, Nephrol Dial Transplant 1998 13 2547 2552 10.1093/ndt/13.10.2547 9794557 (Pubitemid 28445867)
38. Diabetic retinopathy in newly diagnosed middle-aged and elderly diabetic patients. Prevalence and interrelationship with microalbuminuria and triglycerides. NdF Olivarius NV Nielsen AH Andreasen, Graefe's Arch Clin Exp Ophthalmol 2001 239 664 672 10.1007/s004170100324 21497299 (Pubitemid 32927015)
39. Nutritional status in patients with diabetes and chronic kidney disease: a prospective study. C Raffaitin C Lasseur P Chauveau N Barthe H Gin C Combe V Rigalleau, Am J Clin Nutr 2007 85 96 101 17209183 (Pubitemid 46067621)
40. Blood pressure, retinopathy and urinary albumin excretion in IDDM: the EURODIAB IDDM Complications Study. JM Stephenson JH Fuller GC Viberti AK Sjolie R Navalesi, Diabetologia 1995 38 599 603 10.1007/BF00400730 7489844
41. Albuminuria reflects widespread vascular damage. The Steno hypothesis. T Deckert B Feldt-Rasmussen K Borch-Johnsen T Jensen A Kofoed-Enevoldsen, Diabetologia 1989 32 219 226 10.1007/BF00285287 2668076 (Pubitemid 19136363)
42. Haptoglobin phenotype and vascular complications in patients with diabetes. AP Levy A Roguin I Hochberg P Herer S Marsh FM Nakhoul K Skorecki, N Engl J Med 2000 343 969 70 10.1056/NEJM200009283431313 11012324
43. Haptoglobin phenotype and diabetic nephropathy. FM Nakhoul R Zoabi Y Kanter M Zoabi K Skorecki I Hochberg R Leibu B Miller AP Levy, Diabetologia 2001 44 602 604 10.1007/s001250051666 11380078 (Pubitemid 32411276)
44. In vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular disease. R Asleh AP Levy, Vasc Health Risk Manag 2005 1 19 28 10.2147/vhrm.1.1.19.58930 17319095
45. The polymorphism of manganese superoxide dismutase is associated with diabetic nephropathy in Japanese type 2 diabetic patients. T Nomiyama Y Tanaka L Piao K Nagasaka K Sakai T Ogihara K Nakajima H Watada R Kawamori, J Hum Genet 2003 48 138 141 12624725 (Pubitemid 36362514)
46. Co-inheritance of specific genotypes of HSPG and ApoE gene increases risk of type 2 diabetic nephropathy. L Liu K Xiang T Zheng Zhan, Mol Cell Biochem 2003 254 353 358 10.1023/A:1027364121738 14674716 (Pubitemid 37483772)
47. Genetic associations in diabetic nephropathy: a meta-analysis. AL Mooyaart EJ Valk LA van Es JA Bruijn E de Heer BI Freedman OM Dekkers HJ Baelde, Diabetologia 2011 54 544 553 10.1007/s00125-010-1996-1 21127830
48. UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. IM Stratton EM Kohner SJ Aldington RC Turner RR Holman SE Manley DR Matthews, Diabetologia 2001 44 156 163 10.1007/s001250051594 11270671 (Pubitemid 32156199)
49. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. AI Adler IM Stratton HA Neil JS Yudkin DR Matthews CA Cull AD Wright RC Turner RR Holman, BMJ 2000 321 412 419 10.1136/bmj.321.7258.412 10938049 (Pubitemid 30609443)
50. Prevalence of microalbuminuria in older-onset diabetes. R Klein BE Klein SE Moss, Diabetes care 1993 16 1325 1330 10.2337/diacare.16.10.1325 8269789 (Pubitemid 23289470)
51. Association of microalbuminuria and atherosclerotic risk factors in non-diabetic subjects in Korea. CH Kim HK Kim JY Park HS Park SK Hong SW Park KU Lee, Diabetes Res Clin Pract 1998 40 191 199 10.1016/S0168-8227(98)00029-1 9716923 (Pubitemid 28332881)
52. Retinopathy and microalbuminuria in type II diabetic patients. MR Manaviat M Afkhami MR Shoja, BMC Ophthalmol 2004 4 9 10.1186/1471-2415-4-9 15228626
53. Increased urinary albumin excretion is a marker of risk for retinopathy and coronary heart disease in patients with type 2 diabetes mellitus. M Lunetta L Infantone A Calogero E Infantone, Diabetes Res Clin Pract 1998 40 45 51 10.1016/S0168-8227(98)00024-2 9699090 (Pubitemid 28337797)
54. Predictors of mortality of patients newly diagnosed with clinical type 2 diabetes: a 5-year follow up study. NdF Olivarius V Siersma AB Nielsen LJ Hansen L Rosenvinge CE Mogensen, BMC.Endocr.Disord 2010 10 14 10.1186/1472-6823-10-14 20698977
55. The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program. Diabetes Prevention Program Research Group, Diabet Med 2007 24 137 144 17257275
56. Is the presence of microalbuminuria a relevant marker of kidney disease? RJ Glassock, Curr Hypertens Rep 2010 12 364 368 10.1007/s11906-010-0133-3 20686930
57. Changes in insulin sensitivity, renal function and markers of endothelial dysfunction in hypertension - the impact of microalbuminuria: a 13 year follow-up study. MD Solbu TG Jenssen BO Eriksen I Toft, Metabolism 2009 58 408 415 10.1016/j.metabol.2008.10.016 19217459
58. Microalbuminuria is associated with impaired arterial and venous endothelium dependent vasodilation in patients with type 2 diabetes. AM Silva BD Schaan LU Signori RD Plentz H Moreno Jr MC Bertoluci MC Irigoyen, J Endocrinol Invest 2010 33 696 700 20354354
59. Relations of measures of endothelial function and kidney disease: the Framingham Heart Study. MC Foster MJ Keyes MG Larson JA Vita GF Mitchell JB Meigs RS Vasan EJ Benjamin CS Fox, Am J Kidney Dis 2008 52 859 867 10.1053/j.ajkd.2008.04.027 18617305
60. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. P Gaede P Vedel N Larsen GVH Jensen H Parving O Pedersen, N Engl J Med 2003 348 383 393 10.1056/NEJMoa021778 12556541 (Pubitemid 36159355)